100 related articles for article (PubMed ID: 3030341)
1. Epstein-Barr virus infection and oncogenesis in primary immunodeficiency.
Okano M; Osato T; Koizumi S; Imai S; Aya T; Fujiwara S; Mizuno F; Sakiyama Y; Matsumoto S; Sugawara O
AIDS Res; 1986 Dec; 2 Suppl 1():S115-9. PubMed ID: 3030341
[TBL] [Abstract][Full Text] [Related]
2. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
4. Relationship of immunodeficiency to lymphoid malignancy.
Kersey JH; Shapiro RS; Filipovich AH
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
[TBL] [Abstract][Full Text] [Related]
5. [Epstein-Barr virus infection and immune responses in primary immunodeficiency syndromes].
Sakiyama Y
Hokkaido Igaku Zasshi; 1984 Jul; 59(4):379-82. PubMed ID: 6092247
[No Abstract] [Full Text] [Related]
6. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection and the pathogenesis of malignant lymphomas.
Niedobitek G; Young LS; Herbst H
Cancer Surv; 1997; 30():143-62. PubMed ID: 9547991
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Primary immunodeficiencies: genetic risk factors for lymphoma.
Filipovich AH; Mathur A; Kamat D; Shapiro RS
Cancer Res; 1992 Oct; 52(19 Suppl):5465s-5467s. PubMed ID: 1327508
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome.
Gulley ML; Chen CL; Raab-Traub N
Hematol Oncol; 1993; 11(3):139-45. PubMed ID: 8112728
[TBL] [Abstract][Full Text] [Related]
11. Primary immunodeficiency diseases and malignancy in Japan.
Hayakawa H; Kobayashi N; Yata J
Jpn J Cancer Res; 1986 Jan; 77(1):74-9. PubMed ID: 3082818
[TBL] [Abstract][Full Text] [Related]
12. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
14. Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi's lesion or smooth muscle tumors in immunocompetent patients.
Boman F; Gultekin H; Dickman PS
Arch Pathol Lab Med; 1997 Aug; 121(8):834-8. PubMed ID: 9278611
[TBL] [Abstract][Full Text] [Related]
15. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection.
Arber DA; Weiss LM; Albújar PF; Chen YY; Jaffe ES
Am J Surg Pathol; 1993 Apr; 17(4):392-9. PubMed ID: 8388175
[TBL] [Abstract][Full Text] [Related]
16. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
[TBL] [Abstract][Full Text] [Related]
17. The role of Epstein-Barr virus in human B cell malignancies.
Bornkamm GW
Haematologica; 1987; 72(6 Suppl):67-70. PubMed ID: 2832280
[No Abstract] [Full Text] [Related]
18. Responses of lymphocytes to Epstein-Barr virus in patients with primary immunodeficiencies.
Kondo N; Inoue R; Orii T
J Investig Allergol Clin Immunol; 1994; 4(4):182-4. PubMed ID: 7850031
[TBL] [Abstract][Full Text] [Related]
19. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
[TBL] [Abstract][Full Text] [Related]
20. Interactions in immunodeficiency.
Soothill JF
Birth Defects Orig Artic Ser; 1975; 11(1):50-2. PubMed ID: 1096992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
